What Is LL-37?

LL-37 is a naturally occurring antimicrobial peptide in the human body. It belongs to the cathelicidin family and plays a central role in innate immune defense. Your body produces LL-37 in response to infection and tissue damage, where it acts as a first-line defender against bacteria, viruses, and fungi .

The synthetic form of LL-37 used in peptide therapy is identical to the 37-amino-acid sequence your body makes naturally. It has attracted clinical interest for its broad-spectrum antimicrobial activity, wound healing support, and immunomodulatory properties. Research published in journals including the Journal of Immunology and Frontiers in Immunology has explored its therapeutic potential across multiple conditions .

Why Cycling LL-37 Matters

Cycling refers to the practice of using a peptide for a defined period, then taking a break before resuming. With LL-37, cycling is particularly important for three reasons:

1. Preventing Receptor Desensitization

When any signaling molecule is present continuously, the body can downregulate its receptors to maintain homeostasis. LL-37 activates several receptor pathways, including formyl peptide receptor-like 1 (FPRL1) and P2X7 receptors . Taking breaks allows these receptors to reset, so each new cycle delivers the full intended effect.

2. Maintaining Immune Balance

LL-37 is an immunomodulator, not just an immune stimulant. It can both activate and regulate immune responses depending on context. Continuous stimulation without breaks could theoretically shift immune signaling in ways that are counterproductive for long-term health. Cycling supports the body's natural regulatory mechanisms.

3. Monitoring Your Response

Off-cycle periods give you and your physician a window to evaluate how your body responds. Are symptoms improving? Have biomarkers shifted? This information helps refine your protocol for subsequent cycles.

Standard LL-37 Cycling Protocol

These ranges reflect common clinical protocols. Your physician may adjust based on your specific condition, body weight, and treatment goals. Some practitioners use shorter 3-week on / 1-week off cycles for mild immune support, while more aggressive protocols for chronic infections may extend to 8 weeks on with a 4-week break .

How to Structure Your On-Cycle

During your active LL-37 cycle, consistency matters. Here is what we recommend:

• Inject at the same time daily. Most practitioners suggest morning administration to align with natural cortisol and immune rhythms.
• Use subcutaneous injection. The abdominal area and upper thigh are the most common injection sites for LL-37.
• Start at the lower dose. If your physician prescribes a range of 50-100 mcg, begin at 50 mcg for the first week before considering an increase.
• Track your response. Keep a simple log of energy levels, any infection symptoms, injection site reactions, and overall well-being.

For detailed injection guidance, see our LL-37 how to inject guide.

How to Handle the Off-Cycle

The off-cycle is not wasted time. It is a deliberate part of the protocol. During your break:

• Do not abruptly stop other wellness practices. Continue your nutrition, sleep, and exercise routines.
• Monitor for symptom return. If you were using LL-37 for a specific condition, note whether symptoms return during the break and how quickly.
• Support your immune system naturally. Adequate vitamin D (which actually stimulates your body's own LL-37 production), zinc, and sleep are all important during off-cycle periods .
• Check in with your provider. Share your off-cycle observations before starting the next round.

LL-37 Cycling for Specific Goals

Immune Support

For general immune maintenance, a conservative cycle of 4 weeks on / 2 weeks off at 50 mcg daily is a common starting point. Some practitioners recommend seasonal use, running 2 to 3 cycles during fall and winter months when infection risk is higher.

Chronic Infection Management

For persistent infections like Lyme disease or biofilm-associated conditions, longer cycles of 6 to 8 weeks may be used under close medical supervision. Off-cycle periods of 3 to 4 weeks allow for immune reassessment. These protocols often combine LL-37 with other antimicrobial strategies .

Wound Healing and Tissue Repair

Shorter, targeted cycles of 3 to 4 weeks are sometimes used to support wound healing. Once the tissue repair goal is achieved, the peptide is discontinued rather than continued indefinitely.

Combined Peptide Protocols

LL-37 is sometimes used alongside other peptides like BPC-157 or Thymosin Alpha-1. When stacking peptides, cycling becomes even more important. Your physician should coordinate on/off schedules to avoid overstimulating overlapping pathways.

Signs You May Need to Adjust Your Cycle

Pay attention to these signals that your cycling protocol may need modification:

• Diminishing response over time: If each cycle feels less effective, you may need a longer off-cycle to allow full receptor resensitization.
• Increased injection site reactions: Persistent redness or swelling that worsens over a cycle may indicate the need for a break.
• Excessive immune activation: Symptoms like flu-like feelings, joint aches, or fatigue during a cycle could suggest overactivation.
• No noticeable effect: If you feel no difference after 2 to 3 complete cycles, discuss dose adjustments or alternative approaches with your provider.

Frequently Asked Questions

How long should I cycle LL-37?

The most common protocol is 4 to 6 weeks on, followed by 2 to 4 weeks off. Your physician will adjust this based on your treatment goals and response. Chronic conditions may warrant longer cycles with longer breaks.

Can I take LL-37 continuously without cycling?

We do not recommend continuous use. Cycling helps maintain receptor sensitivity and immune balance. Taking LL-37 nonstop may lead to diminishing returns and is not supported by current clinical practice .

What happens if I miss a dose during my on-cycle?

Missing a single dose is unlikely to compromise your cycle. Simply resume your next scheduled injection. Do not double up. If you miss several days, contact your prescribing physician for guidance on whether to continue the current cycle or restart.

Can I cycle LL-37 with other peptides?

Yes, many practitioners combine LL-37 with complementary peptides. The key is coordinating cycling schedules so you are not overstimulating related pathways. Always work with a physician experienced in peptide therapy when using multiple compounds.

How many cycles of LL-37 can I do per year?

There is no hard upper limit, but most patients run 3 to 6 cycles per year depending on their goals. Some use it seasonally for immune support, while others with chronic conditions may cycle more frequently under close supervision.